Showing results (111-120 of 304) with videos related to
Sort By:
Pageof 31
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.Hematology (Amsterdam, Netherlands)|July 14, 2016
The Management of Essential ThrombocythaemiaT Barbui, G Finazzi, T C PearsonBritish Journal of Haematology|September 21, 2000
Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trialG Finazzi, M Ruggeri, F Rodeghiero, et al.Acta Haematologica|January 1, 1996
Role of anthracyclines in the treatment of adult acute lymphoblastic leukemiaR Bassan, T Lerede, A Rambaldi, et al.British Journal of Haematology|August 1, 1983
Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza')T Barbui, G Finazzi, F Rodeghiero, et al.Blood|January 15, 1996
All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4)A Falanga, M Marchetti, S Giovanelli, et al.Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiencyT Barbui, G Cartei, T Chisesi, et al.Leukemia & Lymphoma|September 1, 1996
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia veraR Marchioli, R Landolfi, T Barbui, et al.Leukemia|July 30, 2003
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cellsA Falanga, A Vignoli, M Marchetti, et al.British Journal of Haematology|November 1, 1991
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpuraA Falanga, R Consonni, P Ruggenenti, et al.Pageof 31